Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹-1,066 Cr₹-1,049 Cr₹-1,805 Cr₹-1,655 Cr₹-1,506 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹-1,066 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹-1,066 Cr
Mar2024₹-1,049 Cr
Mar2023₹-1,805 Cr
Mar2022₹-1,655 Cr
Mar2021₹-1,506 Cr

How is Deferred Tax Assets / Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹-1,066 Cr
Negative
Mar2024 ₹-1,049 Cr
Negative
Mar2023 ₹-1,805 Cr
Negative
Mar2022 ₹-1,655 Cr
Negative
Mar2021 ₹-1,506 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹63,832.2 Cr -0.6% -0.1% 0.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,408.0 Cr 1.8% 5.6% 16.7% Stock Analytics
DIVIS LABORATORIES ₹206,906.0 Cr 0.5% 13.1% 10.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,521.0 Cr -2.7% 5.1% 42.4% Stock Analytics
CIPLA ₹119,032.0 Cr 2.1% -0.6% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.1 Cr -4% -17.5% -8.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.6%

-0.1%

0.5%

SENSEX

1.2%

1.2%

-5.5%


You may also like the below Video Courses